Clearance of HBsAg in seven patients with chronic hepatitis B
- PMID: 1332920
- DOI: 10.1002/hep.1840160605
Clearance of HBsAg in seven patients with chronic hepatitis B
Abstract
The natural history of chronic hepatitis B patients who spontaneously cleared serum HBsAg was investigated. A total of 351 patients with chronic hepatitis B were observed in our hospital for at least 3 yr. Seven of these patients became HBsAg negative during the follow-up period. HBsAg disappeared within 6 mo (range = 11 to 169 days, mean = 70 days) after acute elevation of ALT. ALT levels as high as 500 IU were found in three patients, whereas such elevation was not demonstrated in the other four patients. After the disappearance of HBsAg, ALT levels returned to normal in all patients. With one exception, all patients seroconverted to antibody to HBsAg; however, hepatitis B virus DNA remained detectable in serum using the polymerase chain reaction in five patients. The titer of percent inhibition of antibody to HBcAg gradually decreased to less than 70% when a 1:200 dilution of the serum of six patients was used. Four of the patients had active liver disease develop: two had chronic active hepatitis and two had cirrhosis. Three of these four patients subsequently had hepatocellular carcinoma develop. These findings suggest that patients may suffer complications of chronic hepatitis even after normalization of transaminase activities and after the clearance of HBsAg. Thus hepatitis B virus should be considered as a possible factor associated with hepatocellular carcinoma even in the absence of HBsAg, particularly if serum hepatitis B virus DNA persists.
Similar articles
-
Incidence, determinants and significance of delayed clearance of serum HBsAg in chronic hepatitis B virus infection: a prospective study.Hepatology. 1991 Apr;13(4):627-31. Hepatology. 1991. PMID: 2010157
-
Clinical features of HBsAg seroclearance in hepatitis B virus carriers in South Korea: A retrospective longitudinal study.World J Gastroenterol. 2016 Nov 28;22(44):9836-9843. doi: 10.3748/wjg.v22.i44.9836. World J Gastroenterol. 2016. PMID: 27956808 Free PMC article.
-
Persistence of hepatitis B virus DNA in the liver after loss of HBsAg in chronic hepatitis B.Hepatology. 1993 Dec;18(6):1313-8. Hepatology. 1993. PMID: 8244254
-
Natural history of chronic hepatitis B REVEALed.J Gastroenterol Hepatol. 2011 Apr;26(4):628-38. doi: 10.1111/j.1440-1746.2011.06695.x. J Gastroenterol Hepatol. 2011. PMID: 21323729 Review.
-
Occult hepatitis B virus infection.Transfus Clin Biol. 2004 Feb;11(1):18-25. doi: 10.1016/j.tracli.2003.11.007. Transfus Clin Biol. 2004. PMID: 14980545 Review.
Cited by
-
Time to seroconversion of HBsAg to anti-HBs in individuals who lost HBsAg during follow-up.Epidemiol Infect. 2016 Sep;144(12):2648-53. doi: 10.1017/S0950268816001217. Epub 2016 Jun 8. Epidemiol Infect. 2016. PMID: 27268129 Free PMC article.
-
The demographic and paraclinical characteristics of patients with hepatitis B presenting to Shahid Mohammadi Hospital and Clinic and other private clinics in Bandar Abbas, Iran.J Adv Pharm Technol Res. 2018 Oct-Dec;9(4):139-146. doi: 10.4103/japtr.JAPTR_328_18. J Adv Pharm Technol Res. 2018. PMID: 30637232 Free PMC article.
-
Hepatocellular carcinoma (HCC) recurring 10 years after clearance of hepatitis B surface antigen and 20 years after resection of hepatitis B virus-related HCC.Int J Clin Oncol. 2008 Dec;13(6):562-6. doi: 10.1007/s10147-008-0785-z. Epub 2008 Dec 18. Int J Clin Oncol. 2008. PMID: 19093188
-
Cost-effectiveness modelling of birth and infant dose vaccination against hepatitis B virus in Ontario from 2020 to 2050.CMAJ Open. 2023 Jan 10;11(1):E24-E32. doi: 10.9778/cmajo.20210284. Print 2023 Jan-Feb. CMAJ Open. 2023. PMID: 36627129 Free PMC article.
-
Hepatitis B virus persistence after recovery from acute viral hepatitis.J Clin Invest. 1994 Jan;93(1):230-9. doi: 10.1172/JCI116950. J Clin Invest. 1994. PMID: 8282792 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical